EE200200703A - Beeta-blokaatorit ja vajadusel kolesterooli alandavat ainet sisaldav uus ravimvorm - Google Patents

Beeta-blokaatorit ja vajadusel kolesterooli alandavat ainet sisaldav uus ravimvorm

Info

Publication number
EE200200703A
EE200200703A EEP200200703A EEP200200703A EE200200703A EE 200200703 A EE200200703 A EE 200200703A EE P200200703 A EEP200200703 A EE P200200703A EE P200200703 A EEP200200703 A EE P200200703A EE 200200703 A EE200200703 A EE 200200703A
Authority
EE
Estonia
Prior art keywords
blocker
cholesterol
beta
necessary
formulation containing
Prior art date
Application number
EEP200200703A
Other languages
English (en)
Estonian (et)
Inventor
Berglund G�ran
Wikstrand John
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of EE200200703A publication Critical patent/EE200200703A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Pyrrole Compounds (AREA)
EEP200200703A 2000-06-22 2001-06-15 Beeta-blokaatorit ja vajadusel kolesterooli alandavat ainet sisaldav uus ravimvorm EE200200703A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0002354A SE0002354D0 (sv) 2000-06-22 2000-06-22 New formulation
PCT/SE2001/001380 WO2001097751A2 (en) 2000-06-22 2001-06-15 New formulation comprising a betablocker and optionally a cholesterol-lowering agent

Publications (1)

Publication Number Publication Date
EE200200703A true EE200200703A (et) 2004-08-16

Family

ID=20280209

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200703A EE200200703A (et) 2000-06-22 2001-06-15 Beeta-blokaatorit ja vajadusel kolesterooli alandavat ainet sisaldav uus ravimvorm

Country Status (28)

Country Link
US (2) US20030191177A1 (xx)
EP (1) EP1296716B1 (xx)
JP (1) JP2003535875A (xx)
KR (1) KR20030010750A (xx)
CN (1) CN1437484A (xx)
AR (1) AR028699A1 (xx)
AT (1) ATE344675T1 (xx)
AU (1) AU2001274766A1 (xx)
BG (1) BG107373A (xx)
BR (1) BR0111790A (xx)
CA (1) CA2411100A1 (xx)
CZ (1) CZ20024181A3 (xx)
DE (1) DE60124400T2 (xx)
EE (1) EE200200703A (xx)
ES (1) ES2274892T3 (xx)
HK (1) HK1054508A1 (xx)
HU (1) HUP0302371A3 (xx)
IL (1) IL153245A0 (xx)
IS (1) IS6653A (xx)
MX (1) MXPA02012957A (xx)
NO (1) NO20026177D0 (xx)
NZ (1) NZ523188A (xx)
PL (1) PL360484A1 (xx)
RU (1) RU2271802C2 (xx)
SE (1) SE0002354D0 (xx)
SK (1) SK18072002A3 (xx)
WO (1) WO2001097751A2 (xx)
ZA (1) ZA200209908B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8415364B2 (en) 2003-11-26 2013-04-09 Duke University Method of preventing or treating glaucoma
KR100582347B1 (ko) * 2004-12-30 2006-05-22 한미약품 주식회사 3-하이드록시-3-메틸글루타릴 조효소 ａ 환원효소 억제제및 고혈압 치료제의 복합제제 및 그의 제조방법
KR100836321B1 (ko) 2006-10-31 2008-06-09 현대자동차주식회사 차량용 모니터 장치

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175187A (en) * 1989-03-06 1992-12-29 Soorianarain Baligadoo Synergistic compositions for the treatment of coronary insufficiency and methods of use thereof
US5455269A (en) * 1989-03-06 1995-10-03 Baligadoo; Soorianarain Synergistic compositions of amiodarone and beta blockers
EP0576617B1 (en) * 1991-03-18 1996-08-07 Sepracor, Inc. Composition and method containing optically pure (s) metoprolol
JP2648897B2 (ja) * 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
NO177455C (no) * 1993-06-04 1995-09-20 Gerrit Elmenhorst Anordning ved apparat for fremstilling av brannslukkende skum
EP0904082A4 (en) * 1996-04-17 2001-09-26 Merck & Co Inc COMBINATION THERAPY TO REDUCE THE RISKS OF HEART CIRCULAR DISEASES
SE9602762D0 (sv) * 1996-07-12 1996-07-12 Astra Ab Carton and blank for forming the same
US5998458A (en) * 1997-06-25 1999-12-07 University Technology Corporation Method of treating heart failure
GT199800126A (es) * 1997-08-29 2000-01-29 Terapia de combinacion.
ATE248606T1 (de) * 1998-12-23 2003-09-15 Searle Llc Kombinationen einem ibat inhibitor und einem mtp inhibitor für kardiovaskuläre indikationen

Also Published As

Publication number Publication date
KR20030010750A (ko) 2003-02-05
WO2001097751A3 (en) 2002-03-28
BR0111790A (pt) 2003-05-20
JP2003535875A (ja) 2003-12-02
SK18072002A3 (sk) 2003-08-05
ATE344675T1 (de) 2006-11-15
CN1437484A (zh) 2003-08-20
HK1054508A1 (zh) 2003-12-05
MXPA02012957A (es) 2003-05-15
HUP0302371A3 (en) 2007-03-28
AR028699A1 (es) 2003-05-21
PL360484A1 (en) 2004-09-06
NO20026177L (no) 2002-12-20
CZ20024181A3 (cs) 2003-04-16
NZ523188A (en) 2006-06-30
WO2001097751A2 (en) 2001-12-27
ES2274892T3 (es) 2007-06-01
AU2001274766A1 (en) 2002-01-02
BG107373A (bg) 2003-09-30
US20030191177A1 (en) 2003-10-09
NO20026177D0 (no) 2002-12-20
RU2271802C2 (ru) 2006-03-20
IL153245A0 (en) 2003-07-06
ZA200209908B (en) 2004-03-05
DE60124400T2 (de) 2007-10-31
DE60124400D1 (de) 2006-12-21
IS6653A (is) 2002-12-11
EP1296716A2 (en) 2003-04-02
EP1296716B1 (en) 2006-11-08
US20060252814A1 (en) 2006-11-09
SE0002354D0 (sv) 2000-06-22
CA2411100A1 (en) 2001-12-27
HUP0302371A2 (hu) 2003-11-28

Similar Documents

Publication Publication Date Title
EE200000640A (et) Uus kasutamine
NL1016224A1 (nl) Foto-basevormend middel en foto-zuurvormend middel bevattende foto- etssamenstelling.
NO20031672D0 (no) Aza- og polyaza-naftalenylkarboksamider for anvendelse som HIV-integraseinhibitorer
NO20025450L (no) Ny farmasöytisk sammensetning
MA26937A1 (fr) Nouvelle composition pharmaceutique.
NO20012915L (no) Ny farmasöytisk formulering
NO20030494D0 (no) Nye heterosykliske forbindelser, deres fremstilling og deres anvendelse sommedikamenter, s¶rlig som antibakterielle midler
EE200300311A (et) Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim
IT249353Y1 (it) Rete per uso chirurgico.
DE60201461D1 (de) Arbeitsgerät, dessen Benutzer hinterher läuft
ID26774A (id) Senyawa benzimidazol, pembuatan dan penggunaannya sebagai komposisi farmasi
NO20030304D0 (no) Ny kombinasjon av serotoninagonist (5HT2) og antagonist (5HT6) som farmasöytisk formulering
NO954834D0 (no) Lipoprotein-a-senkende middel, kolesterol-senkende middel, samt medikamenter omfattende disse
NO20035121D0 (no) Ny anvendelse
IS2212B (is) 2-(3,5-Bis-trifluoromethyl-phenyl)-N-methyl-N-(6-morpholin-4-yl-4-o-tolyl-pyridin-3-yl)-isobutyrarramide
PT1337528E (pt) Compostos derivados de benzotiofeno, processo de preparacao e a sua utilizacao
EE200200570A (et) Uus beeta-blokaatori ja kolesterooli alandava aine kombinatsioon
DK1149094T3 (da) 4-(aminoalkoxy)-benzofuraner som N-myristoyltransferase-inhibitorer
DE10196021T1 (de) Universeller Vermögenswert- und Beziehungsmanager
EE200000022A (et) Uus ravimvorm
BR0009853B1 (pt) dispositivo de proteÇço de um recipiente, e, recipiente.
ID30464A (id) Pakaian luar sekali pakai untuk operasi pembedahan
EE200200703A (et) Beeta-blokaatorit ja vajadusel kolesterooli alandavat ainet sisaldav uus ravimvorm
NO20034524D0 (no) 5-leddete heterocykler, fremstilling og anvendelse derav som MAO inhibitorer og lipidperoksidasjonsinhibitorer, fremstilling derav oganvendelse derav sommedikamenter
PT1341758E (pt) Coniosetina e seus derivados, processo para a sua preparacao e utilizacao dos mesmos